DOP2019000292A - Método para preparar intermedio de derivado de 4-metoxipirrol - Google Patents
Método para preparar intermedio de derivado de 4-metoxipirrolInfo
- Publication number
- DOP2019000292A DOP2019000292A DO2019000292A DO2019000292A DOP2019000292A DO P2019000292 A DOP2019000292 A DO P2019000292A DO 2019000292 A DO2019000292 A DO 2019000292A DO 2019000292 A DO2019000292 A DO 2019000292A DO P2019000292 A DOP2019000292 A DO P2019000292A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- preparing
- metoxypirrol
- derivative intermediate
- present
- methoxypyrrole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a un método para preparar productos intermedios de derivados de 4-metoxipirrol. El método de preparación según la presente invención tiene las ventajas de que no se requiere una elevada temperatura de reacción en su totalidad, se usan reactivos económicos y no explosivos en lugar de (trimetilsilil)diazometano, y puede prepararse además un producto intermedio de derivados de 4-metoxipirrol en su totalidad a un alto rendimiento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170067646A KR102233456B1 (ko) | 2017-05-31 | 2017-05-31 | 4-메톡시피롤 유도체의 중간체 제조 방법 |
| PCT/KR2018/006188 WO2018221971A1 (en) | 2017-05-31 | 2018-05-31 | Method for preparing intermediate of 4-methoxypyrrole derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2019000292A true DOP2019000292A (es) | 2019-12-15 |
Family
ID=64456008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2019000292A DOP2019000292A (es) | 2017-05-31 | 2019-11-14 | Método para preparar intermedio de derivado de 4-metoxipirrol |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10710961B2 (es) |
| EP (2) | EP4219448A1 (es) |
| JP (1) | JP6799177B2 (es) |
| KR (1) | KR102233456B1 (es) |
| CN (1) | CN110637009B (es) |
| AU (1) | AU2018278731B2 (es) |
| BR (1) | BR112019024976A2 (es) |
| CA (1) | CA3061708C (es) |
| CL (1) | CL2019003449A1 (es) |
| CO (1) | CO2019012686A2 (es) |
| DO (1) | DOP2019000292A (es) |
| EC (1) | ECSP19081839A (es) |
| JO (1) | JOP20190264A1 (es) |
| MA (1) | MA50517A (es) |
| MX (1) | MX2019014323A (es) |
| MY (1) | MY193162A (es) |
| NZ (1) | NZ758743A (es) |
| PE (1) | PE20200399A1 (es) |
| PH (1) | PH12019502638A1 (es) |
| RU (1) | RU2718920C1 (es) |
| SA (1) | SA519410408B1 (es) |
| TN (1) | TN2019000300A1 (es) |
| WO (1) | WO2018221971A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102081920B1 (ko) | 2016-03-25 | 2020-02-26 | 주식회사 대웅제약 | 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형 |
| KR102233455B1 (ko) * | 2017-06-21 | 2021-03-29 | 주식회사 대웅제약 | 4-메톡시피롤 유도체의 중간체 제조 방법 |
| WO2022051979A1 (zh) * | 2020-09-10 | 2022-03-17 | 广东莱佛士制药技术有限公司 | 一种制备钾离子竞争性阻滞剂中间体的方法 |
| CN112094219B (zh) * | 2020-09-10 | 2022-08-05 | 广东莱佛士制药技术有限公司 | 一种制备钾离子竞争性阻滞剂中间体的方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5622948A (en) | 1994-12-01 | 1997-04-22 | Syntex (U.S.A.) Inc. | Pyrrole pyridazine and pyridazinone anti-inflammatory agents |
| KR100286874B1 (ko) | 1998-03-04 | 2001-04-16 | 성재갑 | 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법 |
| WO2006025716A1 (en) | 2004-09-03 | 2006-03-09 | Yuhan Corporation | Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
| US8048909B2 (en) | 2004-09-30 | 2011-11-01 | Takeda Pharmaceutical Company Limited | Proton pump inhibitors |
| DE102004053191A1 (de) | 2004-11-04 | 2006-05-11 | Bayer Cropscience Ag | 2,6-Diethyl-4-methyl-phenyl substituierte Tetramsäure-Derivate |
| JP4481344B2 (ja) | 2005-12-19 | 2010-06-16 | ラクオリア創薬株式会社 | クロマン置換ベンゾイミダゾール誘導体及び酸ポンプ阻害剤としてのそれらの使用 |
| AU2013347383B2 (en) | 2012-11-19 | 2017-04-06 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof |
| KR101613245B1 (ko) | 2015-04-27 | 2016-04-18 | 주식회사 대웅제약 | 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물 |
| KR102081920B1 (ko) | 2016-03-25 | 2020-02-26 | 주식회사 대웅제약 | 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형 |
-
2017
- 2017-05-31 KR KR1020170067646A patent/KR102233456B1/ko active IP Right Grant
- 2017-06-16 JO JOP/2019/0264A patent/JOP20190264A1/ar unknown
-
2018
- 2018-05-31 TN TNP/2019/000300A patent/TN2019000300A1/en unknown
- 2018-05-31 EP EP23165218.1A patent/EP4219448A1/en active Pending
- 2018-05-31 EP EP18809178.9A patent/EP3630722A4/en not_active Ceased
- 2018-05-31 NZ NZ758743A patent/NZ758743A/en unknown
- 2018-05-31 MX MX2019014323A patent/MX2019014323A/es unknown
- 2018-05-31 BR BR112019024976-1A patent/BR112019024976A2/pt unknown
- 2018-05-31 RU RU2019135240A patent/RU2718920C1/ru active
- 2018-05-31 MY MYPI2019006879A patent/MY193162A/en unknown
- 2018-05-31 AU AU2018278731A patent/AU2018278731B2/en active Active
- 2018-05-31 PE PE2019002401A patent/PE20200399A1/es unknown
- 2018-05-31 CN CN201880029533.9A patent/CN110637009B/zh active Active
- 2018-05-31 MA MA050517A patent/MA50517A/fr unknown
- 2018-05-31 US US16/608,910 patent/US10710961B2/en active Active
- 2018-05-31 WO PCT/KR2018/006188 patent/WO2018221971A1/en active Application Filing
- 2018-05-31 CA CA3061708A patent/CA3061708C/en active Active
- 2018-05-31 JP JP2019561188A patent/JP6799177B2/ja active Active
-
2019
- 2019-10-29 SA SA519410408A patent/SA519410408B1/ar unknown
- 2019-11-14 DO DO2019000292A patent/DOP2019000292A/es unknown
- 2019-11-14 CO CONC2019/0012686A patent/CO2019012686A2/es unknown
- 2019-11-15 EC ECSENADI201981839A patent/ECSP19081839A/es unknown
- 2019-11-22 PH PH12019502638A patent/PH12019502638A1/en unknown
- 2019-11-26 CL CL2019003449A patent/CL2019003449A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA50517A (fr) | 2020-09-09 |
| EP3630722A4 (en) | 2020-10-21 |
| TN2019000300A1 (en) | 2021-05-07 |
| US10710961B2 (en) | 2020-07-14 |
| JP6799177B2 (ja) | 2020-12-09 |
| US20200181079A1 (en) | 2020-06-11 |
| JOP20190264A1 (ar) | 2019-11-12 |
| BR112019024976A2 (pt) | 2020-06-23 |
| CN110637009A (zh) | 2019-12-31 |
| NZ758743A (en) | 2022-07-29 |
| CA3061708A1 (en) | 2018-12-06 |
| AU2018278731B2 (en) | 2021-02-18 |
| EP3630722A1 (en) | 2020-04-08 |
| EP4219448A1 (en) | 2023-08-02 |
| PH12019502638A1 (en) | 2020-07-13 |
| WO2018221971A1 (en) | 2018-12-06 |
| MY193162A (en) | 2022-09-26 |
| AU2018278731A1 (en) | 2019-11-21 |
| PE20200399A1 (es) | 2020-02-26 |
| JP2020518647A (ja) | 2020-06-25 |
| CL2019003449A1 (es) | 2020-03-27 |
| KR20180131081A (ko) | 2018-12-10 |
| KR102233456B1 (ko) | 2021-03-29 |
| MX2019014323A (es) | 2020-02-10 |
| SA519410408B1 (ar) | 2021-10-21 |
| CA3061708C (en) | 2021-06-22 |
| CN110637009B (zh) | 2023-11-10 |
| ECSP19081839A (es) | 2019-11-30 |
| RU2718920C1 (ru) | 2020-04-15 |
| CO2019012686A2 (es) | 2020-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2019000292A (es) | Método para preparar intermedio de derivado de 4-metoxipirrol | |
| ECSP19081847A (es) | Método para preparar intermedio de derivado de 4-metoxipirrol | |
| PH12018500093A1 (en) | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol | |
| CL2019002793A1 (es) | Composición para producir tagatosa y procedimiento de producción de tagatosa usando la misma. | |
| BR112015031233A2 (pt) | métodos de produção de derivados de ácidos graxos omega-hidroxilados | |
| BR112015018278A2 (pt) | método para aprimoramento de tolerância à tensão de estiagem de um grão de cereal | |
| MX2019006715A (es) | Metodo de preparacion de compuestos triciclicos. | |
| BR112016025024A2 (pt) | ?processo para preparar compostos ceto, e, uso de farnesil acetona? | |
| EA201690696A1 (ru) | Способ получения адамантанамидов | |
| BR112022008061A2 (pt) | Processo eficaz para síntese de 2-amino-5-cloro-n,3-dimetilbenzamida | |
| MX2016001519A (es) | Derivados de 25-oh vitamina d para determinacion de metabolitos de vitamina d. | |
| BR112017011275A2 (pt) | composição, e, processo para a produção de xarope de glicose. | |
| BR112014008679A2 (pt) | porta-anel, sistema, e, método para conectar um anel a um porta-anel | |
| AR098879A1 (es) | Síntesis de ent-progesterona y sus productos intermedios | |
| WO2016005943A8 (en) | Metal-catalyzed asymmetric 1,4-conjugate addition of vinylboron compounds to 2-substituted-4-oxy- cyclopent-2-en-1-ones yielding prostaglandins and prostaglandin analogs | |
| EP3255271B8 (en) | Cooling mechanism for combustion chamber, rocket engine provided with cooling mechanism, and cooling mechanism production method | |
| BR112015026740A2 (pt) | método para sintetizar derivados de furano, e, método para preparar derivados de furano | |
| TH172005B (th) | อนุพันธ์กรดแอสคอร์บิกและวิธีการสำหรับการผลิตไกลโคไซด์ โดยใช้อนุพันธ์ | |
| BR112018072246A2 (pt) | síntese de indazóis | |
| UA114410U (xx) | Спосіб вилучення цільових компонентів з вуглеводневого газу | |
| PL411140A1 (pl) | Nowe pochodne 1-(piperazyn-1-ylo)-9, 10-antrachinonu funkcjonalizowane wybranymi aminokwasami i sposób ich otrzymywania | |
| CA2935504C (en) | Synthesis method of 9-allylcamptothecin derivatives | |
| BR112017019116A2 (pt) | método para preparar composto de sulfonamida de alta pureza e intermediário do composto de sulfonamida |